WH Group Limited (WHGLY)

CTI BioPharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,832	2,055	1,156	1,394	1,556	1,599
Short-Term Investments	1,071	179	469	282	-	-
Trading Asset Securities	74	310	86	149	232	882
Cash & Short-Term Investments	2,977	2,544	1,711	1,825	1,788	2,481
Cash Growth	113.10%	48.69%	-6.25%	2.07%	-27.93%	148.35%
Accounts Receivable	1,211	888	873	1,087	1,064	915
Other Receivables	128	98	7	6	20	508
Receivables	1,339	986	880	1,093	1,084	1,423
Inventory	4,045	4,083	4,145	4,198	3,888	3,688
Prepaid Expenses	510	568	503	580	668	61
Other Current Assets	70	47	75	313	194	181
Total Current Assets	8,941	8,228	7,314	8,009	7,622	7,834
Property, Plant & Equipment	7,421	7,206	7,503	7,486	7,246	6,350
Long-Term Investments	248	242	226	263	265	364
Goodwill	2,090	2,100	2,043	1,992	2,070	2,008
Other Intangible Assets	1,768	1,699	1,707	1,717	1,757	1,762
Long-Term Deferred Tax Assets	41	54	86	58	42	61
Other Long-Term Assets	337	312	300	330	409	336
Total Assets	20,846	19,841	19,179	19,855	19,411	18,715
Accounts Payable	1,000	1,212	1,240	1,395	1,149	913
Accrued Expenses	1,759	1,945	2,150	2,480	2,371	2,136
Short-Term Debt	-	5	-	-	-	46
Current Portion of Long-Term Debt	1,737	1,049	1,106	862	874	796
Current Portion of Leases	82	71	99	85	110	103
Current Income Taxes Payable	143	109	63	130	71	73
Other Current Liabilities	-	-	-	33	-	-
Total Current Liabilities	4,721	4,391	4,658	4,985	4,575	4,067
Long-Term Debt	2,138	2,256	2,122	2,504	3,140	1,840
Long-Term Leases	395	343	391	449	377	373
Long-Term Unearned Revenue	10	11	10	38	46	44
Long-Term Deferred Tax Liabilities	684	659	570	697	725	553
Other Long-Term Liabilities	521	498	459	408	383	291
Total Liabilities	8,795	8,480	8,604	9,443	9,724	7,730
Common Stock	1	1	1	1	1	1
Additional Paid-In Capital	-	1,083	1,083	1,083	1,083	3,011
Retained Earnings	-	9,582	8,363	8,221	7,162	6,426
Comprehensive Income & Other	10,928	-5	384	295	502	567
Total Common Equity	10,929	10,661	9,831	9,600	8,748	10,005
Minority Interest	1,122	700	744	812	939	980
Shareholders' Equity	12,051	11,361	10,575	10,412	9,687	10,985
Total Liabilities & Equity	20,846	19,841	19,179	19,855	19,411	18,715
Total Debt	4,352	3,724	3,718	3,900	4,501	3,158
Net Cash (Debt)	-1,375	-1,180	-2,007	-2,075	-2,713	-677
Net Cash Per Share	-0.11	-0.09	-0.16	-0.16	-0.19	-0.05
Filing Date Shares Outstanding	12,830	12,830	12,830	12,830	12,830	14,745
Total Common Shares Outstanding	12,830	12,830	12,830	12,830	12,830	14,745
Working Capital	4,220	3,837	2,656	3,024	3,047	3,767
Book Value Per Share	0.85	0.83	0.77	0.75	0.68	0.68
Tangible Book Value	7,071	6,862	6,081	5,891	4,921	6,235
Tangible Book Value Per Share	0.55	0.53	0.47	0.46	0.38	0.42
Land	-	517	584	568	616	552
Buildings	-	4,098	4,069	3,623	3,356	2,992
Machinery	-	6,287	6,077	5,628	5,285	4,887
Construction In Progress	-	344	452	765	720	233

Updated Sep 19, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.